The Prognostic Role Of Interim Pet After First Chemotherapy Cycle And Pet Sequential Evaluation Of Response To Abvd In Hodgkin Lymphoma Patients - The Polish Lymphoma Research Group (Plrg) Observational Study

Background: Several studies confirmed the predictive role on treatment outcome of interim-PET after 2nd ABVD cycle (iPET2) in Hodgkin lymphoma (HL). We hypothesized that interim PET after 1st cycle (iPET1) might define chemosensitivity with a better accuracy than iPET-2. To test this hypothesis, PLRG launched in 2008 a prospective multicenter observational study aiming at assessing the prognostic role of iPET1 and the dynamic of sequential PET response to ABVD.